Member Info for Dibs61

Curve - No. Not sure about warrants but all shares currently held would be reinstated as a part of any delayed RTO beyond the deadline.

A good day but the Question is …. Yet another CGNR False Dawn or the start of a genuinely bright sunny future?

Been here long enough to have a pinch of salt handy

It is absolutely another nothing RNS. Anyone who understands what they are referring to it is the future grant of a CE mark in Europe. Big deal. This is a given. In practical terms it’s a rubber stamp to say it’s safe to use. That’s it. It does not imply anything re sales and the continuing attempts to sustain some hype by the ceo are predictable, repetitive and now lack any credibility whatsoever. Colin King trying to keep the plates spinning.

Go and get yourselves an antigen test. What does it say on it, very clearly. Made in China..

Strikes me that the MM’s seem to constantly have an overload of stock here. This is evident when they are selling stock below the quoted mid price. There simply isn’t the demand for the stock currently and I say that having not sold a single share. We need a catalyst and that catalyst will have to be assay results because the markets not budging on drilling updates. I do also agree there is a lack of understanding of what the porphyry means ie.market superficially looks for eye catching grades.

The wait continues.

One step forwards and two steps back. You need the patience of a saint here!

Clearly a few haven’t!

Minecheck - you make some good points. However, looking at the green investing perspective it’s worth pointing out that POLY is a top 5 global silver producer. Green technologies such as electric cars and solar energy won’t happen without silver.

Interim dividend up from 40c to 45c yoy. Yield 6.1%

That’ll do for me.

Andy - in all fairness you challenged my assertion of ‘stockpiling’ and I simply responded. Fair enough?

I’m not arguing about the emphasis they’ve had on vaccines either. I’m simply saying there has to be an evolution on strategy to include treatments now that it’s obvious that vaccines have not vanquished the virus as politicians like Johnson once suggested.

BTW it’s moot point not mute point. ;)

Andy - the order you refer to is for delivery by end of next year 2022 but is one of Several HUNDRED million vaccines in total already on order by the UK Government. That’s stockpiling by any measure.

Andy - they can order however many vaccines they want. It won’t eliminate the virus. And it’s not like it’s seasonal like the flu either. It’s throughout the year.

This is just rich country stockpiling while poorer countries suffer. It will come back to bite us though.

My point is simple. Vaccines have had their maximum impact now and the virus is still amongst us and will stay amongst us.

We need a range of different treatments to compliment vaccines.

It’s not positive. More drilling because the original plan has been binned as clearly not viable. Just exactly what does Mr Bunn have to back up his fanciful suggestion of a deposit ‘orders of magnitude’ bigger? More AIM bulls*it.

Oh and this is clearly laying the ground for a placing.

Well quite. They have a habit of performing Volta faces. A LOT could change between now and October. It’s abundantly clear Covid is not going away. They’ve played the Vaccine card if I can call it that and put ALL the emphasis on vaccines. You can’t play that card twice. I It is time now to turn their attention to treatments because Vaccines (predictably) have not eliminated the virus as some thought it would.

We NEED treatments and not one treatment but a range of treatments and SNG (provided it produces the necessary results) will be one of a range of treatments. The market is huge and global. Plenty big enough for a tiny company like Synairgen to be transformed and sales to dwarf its current valuation.

Tiger - should’ve known you’d pop up with an attention seeking post. Too good an opportunity to miss though to post a contrarian take. Look let’s be clear the rise is NOT based on ‘pure speculation’. It’s based on FACTUAL INFORMATION which is out there is you look for it.

Now whether or not the SP goes up on the back of this information is another matter but don’t post false suggestions that it’s speculation. It is confirmation on the clinical.gov website that SNG001 has progressed from Activ P2 to P3.

Great work gggg!

And P3 has already started too on 19th August.

Someone must be after the shares today because you can sell at 3.76 above the quoted mid price not to mention the silly UT currently distorting the price down

The substantial market purchase by CB appears to be being largely ignored although in fairness it is THE quietest time of year on the market just now.

Patience….

And finance director has spent £128,750 on these options. Not a small amount….

Oh well that’s it then, we may as well all pack our bags and go home. AAZ have produced a potential therapeutic to meet a given specific market in COVID-19 treatment. No room for us then…lol ….ridiculous isn’t it *rolls eyes*

Buys slightly below quoted mid normally indicate the mms have got a bit too much stock on their hands. We need that supply to be mopped up but it’s holiday season and if you’re ever going to take a break from the market this is it…

Previous short term low was 3.15 hit briefly on 6th July followed by a reasonable bounce. MM’s testing the market for a point of demand with volume pitifully low due to holidays.

This SP drift should not be interpreted as bad drilling news because there is no volume - therefore no selling!

I think the context for the ‘make or break’ comment was that the interviewer had suggested remainder of the year would see much activity across the portfolio. PJ (I believe) is saying that therefore they have to see a breakthrough somewhere in the PF in such a busy period.